Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Today it's been 5 years since my son Matthew's A.V. Canal repair. I remember the nurses: Shannon, Jaime, and Patrick....They were so good with Matthew and with my husband and I.
If it wasn't for Children's Hospital and the Cardiac wing he wouldn't be here. Thank you all for what you have done for us and giving him a chance to grow in front of our eyes! Thank you Dr. Mah, Dr. Baird, and Dr. de Ferranti we owe you the world.
5 years ago today, I placed my one week old son in Dr. Emani's hands to repair his COA. I remember it like it was yesterday, and I'm thankful every day for the care we received at the Heart Center at Boston Children's Hospital.
1 year ago today Dr Baird performed open heart surgery on Cayman. It did NOT slow him down. Today his heart is as good as new and he barely even has a scar. Thank you Dr Baird and everyone on the cardiac floor at Boston Children's Hospital.
Two years ago today we were at Boston Children's Hospital and our daughter, Emily, was having an aortic stent placed. We were told it would have to be replaced by the time she turned 2 (which was last June) but its still in place and working beautifully. We thank God every day for the amazing work of Dr. Gerald Marx and Dr. James Lock.
This weekend we celebrated our beautiful daughter, Mikayla's 1st birthday and that’s thanks to the amazing surgeons and staff on the 8th floor!! Mikayla was born with a rare diagnosis of Pentalogy of Cantrell which included several heart defects.
Fortunately, there is a lot of good news to share about pulmonary hypertension, a condition in which blood pressure in the arteries of the lungs (the pulmonary arteries) is abnormally high. A little more than a decade ago, doctors’ understanding of this condition was crude, and effective therapy was more of a hope than a reality. But thanks to advances in basic science and clinical research, much better therapies have been developed, and nearly every year brings new treatments for this disorder.
The Pulmonary Hypertension Program at Boston Children’s Hospital - part of the #1 ranked Heart Center - is one of the leading pulmonary hypertension programs in the United States.
Pulmonary hypertension is a condition in which blood pressure in the arteries of the lungs (the pulmonary arteries) is abnormally high. As the pressure builds, your heart's right ventricle has to work harder to pump blood through your lungs. This eventually causes your heart muscle to weaken and eventually fail completely.
Unlike other congenital heart conditions, there is no surgical treatment or “cure” for pulmonary hypertension. But treatments are available that can help lessen symptoms and improve your child’s quality of life.
Learn more about pulmonary hypertension and how Boston Children’s cares for children with pulmonary hypertension.
Our program provides comprehensive diagnosis and individualized treatment plans for children and adults with pulmonary hypertension (PH).
Managing pulmonary hypertension requires the combined expertise of many specialists. Our team includes cardiologists, radiologists and pulmonologists who are experts in PH, as well as specially trained nurses who provide helpful assistance and support for families. With particularly difficult cases, we do not hesitate to consult with experts at other hospitals. Our goal is to provide the best care possible to our patients. Please contact us today for a consultation or second opinion.
Researchers at Boston Children's are studying how to prevent and treat pulmonary hypertension. We have participated in prospective trials of inhaled nitric oxide, sildenafil, bosentan and ambrisentan. Current therapeutic trials include evaluation of a new, more efficient way of delivering inhaled iloprost, and a study of the long-term effects of sildenafil and ambrisentan.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”